GALNT7 and prostate neoplasm: Similarly, analysis of a TMA containing 17 normal prostate tissue samples and 79 samples of prostate tumour tissue showed GALNT7 is 2.3 fold upregulated in prostate cancer (p = 0.0124) (Supplementary Figure 1).